These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3153242)

  • 1. Acute leukemia with extramedullary presentation and mixed myeloid and lymphoid expression.
    Bayle C; Romdhane NB; Bastard C; Vannier JP; Hayat M; Lemerle J; Bernard A
    Pediatr Hematol Oncol; 1986; 3(3):293-6. PubMed ID: 3153242
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal development of the acute leukemias.
    Fialkow PJ; Raskind WR; Singer JW; Dow LW; Najfeld V; Veith R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():76-8. PubMed ID: 2653523
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia.
    Lim LC; Heng KK; Vellupillai M; Tan LT; Boey BC; Lau LC; How GF
    Int J Mol Med; 1999 Dec; 4(6):665-7. PubMed ID: 10567681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J; Drach D; Glassl H; Gattringer C; Huber H
    Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
    Hooijkaas H; Adriaansen HJ; van Dongen JJ
    Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlations between acute lymphoid leukemia (ALL) immunophenotype and clinical and laboratory data at presentation. A study of 350 patients.
    Garand R; Vannier JP; Bene MC; Faure GC; Bernard A
    Cancer; 1989 Oct; 64(7):1437-46. PubMed ID: 2673504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification.
    Quintanilla-Martínez L; Zukerberg LR; Ferry JA; Harris NL
    Am J Clin Pathol; 1995 Oct; 104(4):431-43. PubMed ID: 7572794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic classification of acute lymphoblastic leukaemia.
    Ludwig WD; Raghavachar A; Thiel E
    Baillieres Clin Haematol; 1994 Jun; 7(2):235-62. PubMed ID: 7803900
    [No Abstract]   [Full Text] [Related]  

  • 11. Childhood leukemia with simultaneously expressed myeloid and lymphoid markers suggesting stem cell origin.
    Terrin BN; Studer EJ; Wood N; Mohanakumar T; Russell EC
    Am J Hematol; 1985 Oct; 20(2):175-81. PubMed ID: 2412438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic approaches to the classification of lymphomas and lymphoid leukemias.
    Foon KA; Gale RP; Todd RF
    Cancer Treat Res; 1988; 38():1-30. PubMed ID: 2908593
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological and ultrastructural studies in acute biphenotypic leukaemia.
    Shetty V; Chitale A; Matutes E; Buccheri V; Morilla R; Catovsky D
    J Clin Pathol; 1993 Oct; 46(10):903-7. PubMed ID: 8227405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects.
    Adriaansen HJ; Hooijkaas H; Kappers-Klunne MC; Hählen K; van't Veer MB; van Dongen JJ
    Haematol Blood Transfus; 1990; 33():41-9. PubMed ID: 2323649
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
    Altman AJ
    Am J Pediatr Hematol Oncol; 1990; 12(2):123-33. PubMed ID: 2198821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
    Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
    Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
    Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subpopulations of CD10-positive cells in bone marrow of children with acute lymphoblastic leukemia off therapy.
    Molica S; Dattilo A; Consarino C; Puzzonia P; Magro S
    Am J Hematol; 1991 Jul; 37(3):213-4. PubMed ID: 1830453
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune markers in hematologic malignancies.
    Vaickus L; Ball ED; Foon KA
    Crit Rev Oncol Hematol; 1991 Dec; 11(4):267-97. PubMed ID: 1777090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.